Tohoku University Technology: New method for screening mitochondrial function-enhancer: T17-024
Drug-screening method based on new regulatory mechanism of mitochondria & the products
CNS degenerative disorders, including AD and PD, are increasingly believed to be caused due to mitochondrial disability leading to neuronal death. This inventor recently identified a novel intracellular regulatory factor XXX in the CNS neurons that contributes to mitochondrial homeostasis, and the inventor further developed a method for screening beneficial ability of chemicals to enhance mitochondrial function due to elevation of the XXX level.
- Company:Tohoku Techno Arch Co., Ltd.
- Price:Other